Myricetin prevents fibrillogenesis of hen egg white lysozyme

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 39, 2014, Pages 9442-9449

  He, Jianwei ^a   Wang, Yu ^a   Chang, Alan K ^a   Xu, Linan ^b   Wang, Na ^a   Chong, Xiaoying ^a   Li, Hui ^a   Zhang, Bing ^c   Jones, Gary W ^b   Song, Youtao ^a  

^a LIAONING UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

amyloid; lysozyme; molecular docking; molecular dynamics simulation; myricetin

Indexed keywords

AMYLOID; FIBRILLOGENESIS; HEN EGG WHITE LYSOZYME; MOLECULAR DOCKING; MOLECULAR DYNAMICS SIMULATIONS; MYRICETIN;

ENZYMES;

AMYLOID; FLAVONOID; HEN EGG LYSOZYME; LYSOZYME; MYRICETIN; PROTEIN AGGREGATE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CHICKEN; KINETICS; PROTEIN SECONDARY STRUCTURE;

AMYLOID; ANIMALS; CHICKENS; FLAVONOIDS; KINETICS; MODELS, MOLECULAR; MURAMIDASE; PROTEIN AGGREGATES; PROTEIN STRUCTURE, SECONDARY;

EID: 84907484360     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf5025449     Document Type: Article

References (62)

1. Sipe, J. D.; Benson, M. D.; Buxbaum, J. N.; Ikeda, S.; Merlini, G.; Saraiva, M. J.; Westermark, P. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 2012, 19 (4) 167-70
2. Pepys, M. B.; Hawkins, P. N.; Booth, D. R.; Vigushin, D. M.; Tennent, G. A.; Soutar, A. K.; Totty, N.; Nguyen, O.; Blake, C. C.; Terry, C. J. Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 1993, 362 (6420) 553-7
3. Valleix, S.; Drunat, S.; Philit, J. B.; Adoue, D.; Piette, J. C.; Droz, D.; MacGregor, B.; Canet, D.; Delpech, M.; Grateau, G. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family Kidney Int. 2002, 61 (3) 907-12
4. Yazaki, M.; Farrell, S. A.; Benson, M. D. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis Kidney Int. 2003, 63 (5) 1652-7
5. Rocken, C.; Becker, K.; Fandrich, M.; Schroeckh, V.; Stix, B.; Rath, T.; Kahne, T.; Dierkes, J.; Roessner, A.; Albert, F. W. ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene Human Mutat. 2006, 27 (1) 119-20
6. Palmer, A. M. Neuroprotective therapeutics for Alzheimer's disease: Progress and prospects Trends Pharmacol. Sci. 2011, 32 (3) 141-7
7. Cohen, F. E.; Kelly, J. W. Therapeutic approaches to protein-misfolding diseases Nature 2003, 426 (6968) 905-9
8. Gazit, E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool FEBS J. 2005, 272 (23) 5971-8
9. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism Chem. Biol. Drug Des. 2006, 67 (1) 27-37
10. Ghosh, S.; Pandey, N. K.; Dasgupta, S. (-)-Epicatechin gallate prevents alkali-salt mediated fibrillogenesis of hen egg white lysozyme Int. J. Biol. Macromol. 2013, 54, 90-8
11. Wang, S. S.; Liu, K. N.; Lee, W. H. Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme Biophys. Chem. 2009, 144 (1-2) 78-87
12. Vuong, Q. V.; Siposova, K.; Nguyen, T. T.; Antosova, A.; Balogova, L.; Drajna, L.; Imrich, J.; Li, M. S.; Gazova, Z. Binding of glyco-acridine derivatives to lysozyme leads to inhibition of amyloid fibrillization Biomacromolecules 2013, 14 (4) 1035-43
13. Gazova, Z.; Bellova, A.; Daxnerova, Z.; Imrich, J.; Kristian, P.; Tomascikova, J.; Bagelova, J.; Fedunova, D.; Antalik, M. Acridine derivatives inhibit lysozyme aggregation Eur. Biophys. J. 2008, 37 (7) 1261-70
14. Antosova, A.; Chelli, B.; Bystrenova, E.; Siposova, K.; Valle, F.; Imrich, J.; Vilkova, M.; Kristian, P.; Biscarini, F.; Gazova, Z. Structure-activity relationship of acridine derivatives to amyloid aggregation of lysozyme Biochim. Biophys. Acta 2011, 1810 (4) 465-74
15. Wu, J. W.; Liu, K. N.; How, S. C.; Chen, W. A.; Lai, C. M.; Liu, H. S.; Hu, C. J.; Wang, S. S. Carnosine's effect on amyloid fibril formation and induced cytotoxicity of lysozyme PLoS One 2013, 8 (12) e81982
16. Stefani, M.; Rigacci, S. Protein folding and aggregation into amyloid: The interference by natural phenolic compounds Int. J. Mol. Sci. 2013, 14 (6) 12411-57
17. Akaishi, T.; Morimoto, T.; Shibao, M.; Watanabe, S.; Sakai-Kato, K.; Utsunomiya-Tate, N.; Abe, K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein Neurosci. Lett. 2008, 444 (3) 280-5
18. McKoy, A. F.; Chen, J.; Schupbach, T.; Hecht, M. H. A novel inhibitor of amyloid beta (Abeta) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease J. Biol. Chem. 2012, 287 (46) 38992-9000
19. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 2008, 15 (6) 558-66
20. Bulic, B.; Pickhardt, M.; Schmidt, B.; Mandelkow, E. M.; Waldmann, H.; Mandelkow, E. Development of tau aggregation inhibitors for Alzheimer's disease Angew. Chem. 2009, 48 (10) 1740-52
21. Ono, K.; Yamada, M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro J. Neurochem. 2006, 97 (1) 105-15
22. Zelus, C.; Fox, A.; Calciano, A.; Faridian, B. S.; Nogaj, L. A.; Moffet, D. A. Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity Open Biochem. J. 2012, 6, 66-70
23. Frare, E.; Polverino De Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A highly amyloidogenic region of hen lysozyme J. Mol. Biol. 2004, 340 (5) 1153-65
24. Hess, B.; Kutzner, C.; Van Der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theory Comput. 2008, 4, 435-447
25. Refaee, M.; Tezuka, T.; Akasaka, K.; Williamson, M. P. Pressure-dependent changes in the solution structure of hen egg-white lysozyme J. Mol. Biol. 2003, 327 (4) 857-65
26. Scott, W. R. P.; Hünenberger, P. H.; Tironi, I. G.; Mark, A. E.; Billeter, S. R.; Fennen, J.; Torda, A. E.; Huber, T.; Krüger, P.; van Gunsteren, W. F. The GROMOS biomolecular simulation program package J. Phys. Chem. A 1999, 103, 3596-607
27. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; Hermans, J. Interaction models for water in relation to protein hydration Intermol. Forces 1981, 11 (Suppl. 1) 331-8
28. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H. J.; Pedersen, L. G. A smooth particle mesh Ewald potential J. Chem. Phys. 1995, 103, 8577-92
29. Chen, C. Y. TCM Database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico PLoS One 2011, 6 (1 e15939
30. Swaminathan, R.; Ravi, V. K.; Kumar, S.; Kumar, M. V.; Chandra, N. Lysozyme: A model protein for amyloid research Adv. Protein Chem. Struct Biol. 2011, 84, 63-111
31. LeVine, H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 1993, 2 (3) 404-10
32. Semisotnov, G. V.; Rodionova, N. A.; Razgulyaev, O. I.; Uversky, V. N.; Gripas, A. F.; Gilmanshin, R. I. Study of the ″molten globule″ intermediate state in protein folding by a hydrophobic fluorescent probe Biopolymers 1991, 31 (1) 119-28
33. Cowgill, R. W. Fluorescence and the Structure of Proteins. Ii. Fluorescence of Peptides Containing Tryptophan or Tyrosine Biochim. Biophys. Acta 1963, 75, 272-3
34. Di Stasio, E.; Bizzarri, P.; Misiti, F.; Pavoni, E.; Brancaccio, A. A fast and accurate procedure to collect and analyze unfolding fluorescence signal: The case of dystroglycan domains Biophys. Chem. 2004, 107 (2) 197-211
35. Duy, C.; Fitter, J. How aggregation and conformational scrambling of unfolded states govern fluorescence emission spectra Biophys. J. 2006, 90 (10) 3704-11
36. Suryaprakash, P.; Kumar, R. P.; Prakash, V. Thermodynamics of interaction of caffeic acid and quinic acid with multisubunit proteins Int. J. Biol. Macromol. 2000, 27 (3) 219-28
37. Rawel, H. M.; Czajka, D.; Rohn, S.; Kroll, J. Interactions of different phenolic acids and flavonoids with soy proteins Int. J. Biol. Macromol. 2002, 30 (3-4) 137-50
38. Gama Sosa, M. A.; De Gasperi, R.; Elder, G. A. Modeling human neurodegenerative diseases in transgenic systems Hum. Genet. 2012, 131 (4) 535-63
39. Kikis, E. A.; Gidalevitz, T.; Morimoto, R. I. Protein homeostasis in models of aging and age-related conformational disease Adv. Exp. Med. Biol. 2010, 694, 138-59
40. Cuanalo-Contreras, K.; Mukherjee, A.; Soto, C. Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging Int. J. Cell Biol. 2013, 2013 638083
41. Demontis, F.; Perrimon, N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging Cell 2010, 143 (5) 813-25
42. Ben-Zvi, A.; Miller, E. A.; Morimoto, R. I. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (35) 14914-9
43. Cohen, E.; Paulsson, J. F.; Blinder, P.; Burstyn-Cohen, T.; Du, D.; Estepa, G.; Adame, A.; Pham, H. M.; Holzenberger, M.; Kelly, J. W.; Masliah, E.; Dillin, A. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice Cell 2009, 139 (6) 1157-69
44. Truelsen, T.; Thudium, D.; Gronbaek, M.; Copenhagen City Heart Study. Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study Neurology 2002, 59 (9) 1313-9
45. Ono, K.; Li, L.; Takamura, Y.; Yoshiike, Y.; Zhu, L.; Han, F.; Mao, X.; Ikeda, T.; Takasaki, J.; Nishijo, H.; Takashima, A.; Teplow, D. B.; Zagorski, M. G.; Yamada, M. Phenolic compounds prevent amyloid beta-protein oligomerization and synaptic dysfunction by site-specific binding J. Biol. Chem. 2012, 287 (18) 14631-43
46. Smid, S. D.; Maag, J. L.; Musgrave, I. F. Dietary polyphenol-derived protection against neurotoxic beta-amyloid protein: From molecular to clinical Food Funct. 2012, 3 (12) 1242-50
47. Cazarolli, L. H.; Zanatta, L.; Alberton, E. H.; Figueiredo, M. S.; Folador, P.; Damazio, R. G.; Pizzolatti, M. G.; Silva, F. R. Flavonoids: Cellular and molecular mechanism of action in glucose homeostasis Mini-Rev. Med. Chem. 2008, 8 (10) 1032-8
48. Narayana, K. R.; Reddy, M. S.; Chaluvadi, M. R.; Krishna, D. R. Bioflavonoids classification, pharmacological, biochemical effects and therapeutic potential Indian J. Pharmacol. 2001, 33 (1) 2-16
49. Hudson, S. A.; Ecroyd, H.; Kee, T. W.; Carver, J. A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds FEBS J. 2009, 276 (20) 5960-72
50. Canet, D.; Last, A. M.; Tito, P.; Sunde, M.; Spencer, A.; Archer, D. B.; Redfield, C.; Robinson, C. V.; Dobson, C. M. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme Nat. Struct. Biol. 2002, 9 (4) 308-15
51. Dumoulin, M.; Canet, D.; Last, A. M.; Pardon, E.; Archer, D. B.; Muyldermans, S.; Wyns, L.; Matagne, A.; Robinson, C. V.; Redfield, C.; Dobson, C. M. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations J. Mol. Biol. 2005, 346 (3) 773-88
52. Tokunaga, Y.; Sakakibara, Y.; Kamada, Y.; Watanabe, K.; Sugimoto, Y. Analysis of core region from egg white lysozyme forming amyloid fibrils Int. J. Biol. Sci. 2013, 9 (2) 219-27
53. Lara, C.; Reynolds, N. P.; Berryman, J. T.; Xu, A.; Zhang, A.; Mezzenga, R. ILQINS hexapeptide, identified in lysozyme left-handed helical ribbons and nanotubes, forms right-handed helical ribbons and crystals J. Am. Chem. Soc. 2014, 136 (12) 4732-9
54. Leach, A. R.; Shoichet, B. K.; Peishoff, C. E. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps J. Med. Chem. 2006, 49 (20) 5851-5
55. Kann, M. G. Protein interactions and disease: Computational approaches to uncover the etiology of diseases Briefings Bioinf. 2007, 8 (5) 333-46
56. Imoto, T.; Forster, L. S.; Rupley, J. A.; Tanaka, F. Fluorescence of lysozyme: emissions from tryptophan residues 62 and 108 and energy migration Proc. Natl. Acad. Sci. U. S. A. 1972, 69 (5) 1151-5
57. Bahramikia, S.; Yazdanparast, R. Anti-amyloidogenic and fibril-destabilizing effects of two manganese-salen derivatives against hen egg-white lysozyme aggregation Int. J. Biol. Macromol. 2012, 50 (1) 187-97
58. Kalyan, S. G.; Bijaya, K. S.; Swagata, D. Spectrophotometric studies on the interaction between (-)-epigallocatechin-3-gallate and lysozyme Chem. Phys. Lett. 2008, 452, 193-7
59. Phillips, D. C. The three-dimensional structure of an enzyme molecule Sci. Am. 1966, 215 (5) 78-90
60. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M.; Stefani, M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 2002, 416 (6880) 507-11
61. Lorenzo, A.; Yankner, B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (25) 12243-7
62. Ghosh, S.; Pandey, N. K.; Banerjee, P.; Chaudhury, K.; Nagy, N. V.; Dasgupta, S. Copper(II) directs formation of toxic amorphous aggregates resulting in inhibition of hen egg white lysozyme fibrillation under alkaline salt-mediated conditions J. Biomol. Struct. Dyn. 2014, 1-17